Wexford Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,250
| Closed | -$491K | – | 114 |
|
|
2019
Q1 | $491K | Sell |
5,250
-5,000
| -49% | -$468K | 0.04% | 80 |
|
|
2018
Q4 | $747K | Sell |
10,250
-6,000
| -37% | -$437K | 0.06% | 59 |
|
|
2018
Q3 | $1.42M | Hold |
16,250
| – | – | 0.09% | 95 |
|
|
2018
Q2 | $1.6M | Hold |
16,250
| – | – | 0.1% | 76 |
|
|
2018
Q1 | $1.94M | Buy |
+16,250
| New | +$1.94M | 0.14% | 59 |
|
|
2017
Q3 | – | Sell |
-4,300
| Closed | -$343K | – | 144 |
|
|
2017
Q2 | $343K | Buy |
+4,300
| New | +$343K | 0.03% | 144 |
|